Racial Disparities in Myeloma Treatment Nationwide

Blood cancer specialist Sikander Ailawadhi, M.D., was working in a county hospital in California several years ago when he became aware of a trend in cancer care that was concerning.

“I noticed patient profiles from different racial subgroups seemed to get different treatments and have different outcomes,” says Dr. Ailawadhi, a specialist in multiple myeloma and now vice chair of clinical practice for hematology on Mayo Clinic’s campus in Florida.

Those observations led to an investigation of health disparities across the country among patients with myeloma published in the journal Cancer.

Read the full story in Discovery's Edge magazine.

Please sign in or register to post a reply.